Shanghai INT Medical Instruments Co (HKSE:01501) LT-Debt-to-Total-Asset : 0.01 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Shanghai INT Medical Instruments Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.01.

Shanghai INT Medical Instruments Co's long-term debt to total assets ratio declined from Dec. 2022 (0.01) to Dec. 2023 (0.01). It may suggest that Shanghai INT Medical Instruments Co is progressively becoming less dependent on debt to grow their business.

Shanghai INT Medical Instruments Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co LT-Debt-to-Total-Asset Chart

Shanghai INT Medical Instruments Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

Shanghai INT Medical Instruments Co Semi-Annual Data
	Dec16	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial								0.01	0.01	0.01	0.01	0.01

Shanghai INT Medical Instruments Co LT-Debt-to-Total-Asset Calculation

Shanghai INT Medical Instruments Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	17.124	/	2219.962
	=	0.01

Shanghai INT Medical Instruments Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	17.124	/	2219.962
	=	0.01

Shanghai INT Medical Instruments Co (HKSE:01501) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Shanghai INT Medical Instruments Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai INT Medical Instruments Co (HKSE:01501) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803

Website

https://www.kdl-int.com

Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.

Shanghai INT Medical Instruments Co (HKSE:01501) Headlines

No Headlines